Boyd Holly, Santos Alexandra F
Department of Women and Children's Health (Pediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom; Children's Allergy Service, Evelina London Children's Hospital, Guy's and St Thomas' Hospital, London, United Kingdom.
Department of Women and Children's Health (Pediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom; Children's Allergy Service, Evelina London Children's Hospital, Guy's and St Thomas' Hospital, London, United Kingdom.
J Allergy Clin Immunol. 2025 Feb;155(2):275-285. doi: 10.1016/j.jaci.2024.12.1071. Epub 2024 Dec 20.
Food allergy is increasing in prevalence, posing significant challenges for individuals and their families and adversely affecting their quality of life. Misdiagnosis can lead to unnecessary dietary and social limitations and increased food allergy risk, whereas failure to diagnose may result in life-threatening anaphylaxis. Therefore, a precise diagnosis is of the utmost importance; however, barriers exist at every stage of the diagnostic process. Diagnosis of food allergy relies on clinical history, IgE sensitization tests, and oral food challenge. Component testing and identification of optimal cutoffs have improved diagnostic accuracy. Nevertheless, many patients still require an oral food challenge, and better tests are needed to reduce this need. Novel ways of detecting biomarkers, such as the basophil activation test and peptide-specific IgE level, are transitioning into clinical practice. Future approaches may include the use of alternative biologic samples, novel laboratory technologies, and analytic tools (including artificial intelligence) to integrate test results and clinical information. Conscientious use of existing tests, access to tests with superior diagnostic accuracy, and combination of tests, can lead to improved precision of diagnosis of food allergy and timely introduction of tolerated foods into the diet. This review summarizes recent advances in novel approaches to food allergy diagnosis that can enhance clinical decision making both now and in the future.
食物过敏的患病率正在上升,给个人及其家庭带来重大挑战,并对他们的生活质量产生不利影响。误诊会导致不必要的饮食和社交限制以及食物过敏风险增加,而漏诊可能会导致危及生命的过敏反应。因此,精确诊断至关重要;然而,诊断过程的每个阶段都存在障碍。食物过敏的诊断依赖于临床病史、IgE致敏试验和口服食物激发试验。成分检测和最佳临界值的确定提高了诊断准确性。尽管如此,许多患者仍需要进行口服食物激发试验,因此需要更好的检测方法来减少这种需求。检测生物标志物的新方法,如嗜碱性粒细胞活化试验和肽特异性IgE水平,正在向临床实践转化。未来的方法可能包括使用替代生物样本、新型实验室技术和分析工具(包括人工智能)来整合检测结果和临床信息。认真使用现有检测方法、获得具有更高诊断准确性的检测方法以及联合检测,可以提高食物过敏诊断的准确性,并及时将耐受食物引入饮食中。本综述总结了食物过敏诊断新方法的最新进展,这些进展可以在现在和未来增强临床决策。